Skip to main content
Supplement ScienceSupplementScience

Surrogate vs. Clinical Endpoints: What a Study Actually Measured

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

A surrogate endpoint is a measurable stand-in — like LDL cholesterol, blood pressure, or bone density — used to predict...

A surrogate endpoint is a measurable stand-in — like LDL cholesterol, blood pressure, or bone density — used to predict an outcome people truly care about, such as living longer or having fewer fractures. A supplement can move a surrogate marker without improving the real-world outcome, so surrogate results should be read with caution.

Key Takeaways

  • Clinical endpoints are outcomes people experience; surrogate endpoints are lab markers used as stand-ins.
  • A supplement can shift a surrogate marker without improving the real-world outcome.
  • 'Lowers cholesterol' or 'raises antioxidant levels' are surrogates — not the same as better health.
  • Even in drug testing, a surrogate is accepted only when strong evidence links it to a real outcome.
  • Favor evidence measured on outcomes that matter to you over marker-only results.

Get the free evidence-based Surrogate vs. Clinical Endpoints: What a Study Actually Measured guide — delivered in 60 seconds.

No spam. Unsubscribe anytime.

Two kinds of 'it worked'

When a study says a supplement 'worked,' it is worth asking *what was actually measured.* Researchers separate two kinds of outcomes [1]:

  • Clinical endpoints are things people directly experience or care about: living longer, avoiding a fracture, having fewer cardiovascular events, functioning better day to day.
  • Surrogate endpoints are markers — LDL cholesterol, blood pressure, blood sugar, bone mineral density, an inflammatory marker — used as a *stand-in* because they are faster and cheaper to measure.

Why surrogates can mislead

A surrogate is only useful if changing it reliably changes the outcome that matters. Often it does not. A supplement might nudge a blood marker in the 'right' direction while making no difference to how long or how well people live. Medicine has many examples of interventions that improved a surrogate yet failed — or even backfired — on the real outcome when properly tested.

Examples relevant to supplements

  • 'Lowers cholesterol' (surrogate) is not the same as 'reduces cardiovascular events' (clinical).
  • 'Raises antioxidant levels in the blood' (surrogate) is not the same as 'helps people live longer' (clinical).
  • 'Increases bone density on a scan' (surrogate) is a step toward, but not the same as, 'fewer broken bones' (clinical).

A higher bar in drug testing

In drug development the bar is higher than for dietary supplements: a marker is generally accepted as a surrogate only when strong evidence ties it to a real outcome, and approvals granted on a surrogate still call for follow-up trials that measure actual outcomes. Supplements are not held to that standard, so surrogate-only evidence is more common — keep the gap between 'changed a marker' and 'changed my health' in mind [2].

The takeaway for label-reading

When a product cites impressive 'clinically studied' markers, check whether those are surrogates or real outcomes. Marker improvements are a promising signal, not a finished story. Independent trials measuring outcomes people actually experience are the gold standard.

Frequently Asked Questions

What is a surrogate endpoint in plain English?

It is a measurable stand-in that researchers hope predicts something you care about. Cholesterol level, blood pressure, and bone density are surrogates; living longer or avoiding a fracture is the real outcome they are meant to predict.

Why do so many supplement studies use surrogate markers?

Markers are faster and cheaper to measure. Showing a change in a blood marker can be done in a short, small study, whereas showing a change in a real-life outcome usually needs far more people followed for much longer.

If a supplement improves a marker, did it improve my health?

Not necessarily. A marker moving in a favorable direction is encouraging, but only outcome-based trials show whether that translates into feeling better or living longer. Treat marker-only results as preliminary rather than conclusive.

How can I tell which kind of endpoint a study used?

Read what the study actually measured. If the headline result is a lab value (cholesterol, a hormone, an inflammatory marker), it is a surrogate. If it is an event people experience, such as a fracture or a hospitalization, it is a clinical endpoint.

References

  1. National Center for Complementary and Integrative Health (2026). How To Make Sense of a Scientific Journal Article. U.S. National Institutes of Health.
  2. National Center for Complementary and Integrative Health (2026). Know the Science. U.S. National Institutes of Health.